Retour
Prix Roivant Sciences Ltd (ROIV)
Graphique du cours de l'action ROIV
ROIV Gagner
Roivant Sciences Ltd
$23.13
-0.72%
$-0.17
À la fermeture : Jan 16, 16:00:00 GMT-5
$23.4
1.16%
$0.26
Post-Marché: Jan 16, 20:00:00 GMT-5
A
Résultat final
Statistiques clés
Clôture préc.
$23.3
Prix d'ouverture
$22.85
Plage de la journée
$22.16 - $23.4
Plage de 52 semaines
$8.73 - $23.47
Volume
8.1M
Volume moyen
8.2M
BPA (TTM)
-0.55
Rendement en dividend
--
Capitalisation boursière
$16.2B
Qu’est-ce que ROIV ?
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. The Company’s pipeline includes brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis and cutaneous sarcoidosis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. The company also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.
Fonctionnalités
Stratégies de trading
Ressources
© 2025 Finture Development Limited. All rights reserved